Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Bombay High Court...

    Bombay High Court directs Nuziveedu Seeds to pay Rs 138 crore dues of Mahyco Monsanto Biotech

    GarimaWritten by Garima Published On 2019-03-09T09:30:32+05:30  |  Updated On 9 March 2019 9:30 AM IST
    Bombay High Court directs Nuziveedu Seeds to pay Rs 138 crore dues of Mahyco Monsanto Biotech

    According to a statement released by MMBL, Nuziveedu Seeds Ltd (NSL) and several other seed makers stopped payment of trait fee on the technology to the biotech company in 2015, arguing the technology had turned ineffective and so, they need not pay royalty.


    Mumbai: The Bombay High Court has directed Hyderabad-based Nuziveedu Seeds Ltd (NSL) to deposit Rs 138 crore in the court towards payment of its dues to biotechnology company Mahyco Monsanto Biotech Ltd (MMBL). MMBL sells Bt technology to cotton seed companies under sub-licence agreements.


    According to a statement released by MMBL, NSL and several other seed makers stopped payment of trait fee on the technology to the biotech company in 2015, arguing the technology had turned ineffective and so, they need not pay royalty.


    As per the statement, around 15 seed companies, including NSL, owed Rs 450 crore to MMBL. Of these, all but NSL group companies agreed to settle the issue and pay up.


    Also Read: Lupin posts Rs 783.5 crore net loss in Q4 due to one-time impairment


    MMBL and NSL subsequently took the matter for arbitration and in January this year, the arbitration tribunal directed NSL to pay around Rs 117 crore to MMBL towards trait value for all sales in 2015.


    MMBL then filed a petition in the high court seeking to enforce the tribunal's order.


    On Wednesday, a single bench presided over by Justice G S Kulkarni passed an order holding that prima facie, the tribunal order was valid.


    Justice Kulkarni directed NSL to deposit in the high court the amount ordered by the tribunal and the interest accrued upon the same within two weeks. The sum comes to around Rs 138 crore.


    The bench asked NSL to deposit the amount either in cash or through bank guarantees.


    The court also asked NSL not to dispose any of its assets till it deposits Rs 138 crore towards payment of dues.







    Nuziveedu Seeds is an Indian agribusiness company which notably markets seeds. Nuziveedu Seeds Ltd. has played a role in Indian agriculture by developing and supplying quality hybrids and varietal seeds to millions of farmers.






    Also Read: Bayer says Monsanto India integration to complete in one year
    biotechBiotech LtdBiotechnologyBombay High Courtdueindian industry newsindustry growthindustry newsMahycoMahyco Monsanto BiotechMonsantoMumbai High CourtNSLNSL duesNuziveedu Seeds Ltd
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok